Antiobesity Activity of Two Polyherbal Formulations in High-Fat Diet-Induced Obese C57BL/6J Mice.

Biomed Res Int

Department of Oriental Pharmacy and Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Sinyong-Dong, Iksan 570-749, Republic of Korea.

Published: June 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Obesity and overweight have posed a severe threat to humanity, needing urgent efforts for the development of safe and effective therapeutic interventions. In this research work, we have developed two polyherbal formulations A and B basically consisting of root powder (also called inulin of synanthrin) along with other herbs for the treatment of obesity. Evaluation of the antioxidant activity of both formulations using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) free radical scavenging assays showed good antioxidant potentials. Both formulations A and B showed good antiobesity activity on a diet-induced obesity (DIO) model of mice by effectively lowering the body weight of mice compared to the high-fat diet (HFD) control mice, mainly by reducing the food efficiency ratio (FER). Furthermore, both formulations ameliorated lipoprotein misbalances induced by obesity and thus decreased the atherogenic index. Treatment with both formulations significantly decreased the liver and epididymal white adipose tissue (WAT) weight. This was supported by the improvement in steatosis of the liver and reduced hypertrophy in WAT on histological examination. In addition, formulations A and B have been seen as effective in controlling fasting blood glucose levels probably by alleviating HFD-induced insulin resistance. All of these results collectively suggest that formulations A and B serve as potentially safe and effective herbal interventions to control obesity and its comorbidities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192239PMC
http://dx.doi.org/10.1155/2022/9120259DOI Listing

Publication Analysis

Top Keywords

antiobesity activity
8
formulations
8
polyherbal formulations
8
safe effective
8
obesity
5
activity polyherbal
4
formulations high-fat
4
high-fat diet-induced
4
diet-induced obese
4
obese c57bl/6j
4

Similar Publications

Introduction: Obesity remains a critical global health challenge, intricately linked to poor dietary quality, gut microbiota dysbiosis, and mitochondrial dysfunction.

Purpose: This study aimed to investigate the comparative effects of brown rice, meal replacements, and thiazolidinediones on mitochondrial abundance and gut microbiota composition in a rat model of diet-induced obesity.

Methods And Materials: A total of twenty male Sprague Dawley rats were randomly assigned to five groups: control, high-fat high-fructose diet, and three intervention groups receiving the same obesogenic diet supplemented with brown rice, meal replacement, or thiazolidinediones for twelve weeks.

View Article and Find Full Text PDF

Ellagic acid (EA), a bioactive polyphenol abundant in pomegranate and berries, exhibits potential in metabolic regulation. This study investigates EA's anti-obesity mechanisms, focusing on its effects on gut microbiota and transcriptional regulation in adipose tissue. After a 9-week high-fat diet feeding, mice were divided into groups and treated with low-dose EA (10 mg/kg/day), high-dose EA (30 mg/kg/day), or urolithin A (20 mg/kg/day) for 7 weeks, with healthy and obese controls included.

View Article and Find Full Text PDF

Coextraction of Citrullus lanatus seeds and Citrus aurantium peels (1:1, w/w), two food processing wastes, was performed using supercritical carbon dioxide (scCO) (345 bar|57 °C|178 min) and pet ether solvents. The major objective of the study was to valorize two fruit processing wastes to obtain a bioactive coextract using a green scCO extraction process and further incorporate it into wax-based composite oleofoams. The scCO coextraction resulted in better extraction of bioactive compounds such as d-limonene and polyunsaturated fatty acids due to the absence of light and lower temperature of extraction, compared to pet ether.

View Article and Find Full Text PDF

A Review of Amylin Peptide Receptor Activators for Obesity Pharmacotherapy.

Curr Drug Targets

August 2025

Department of Medicinal Biotechnology, College of Health Science, Dong-A University, Busan, 49315, Republic of Korea.

Amylin is a thirty-seven amino acid peptide hormone that is secreted from the pancreas with insulin. The peptide hormone amylin activates its receptors in the brain to regulate blood glucose and food appetite. Interestingly, the amylin receptor is the heterodimer of the calcitonin receptor (which is the receptor for the peptide hormone calcitonin) and an accessory protein called receptor activity-modifying protein.

View Article and Find Full Text PDF

Obesity significantly impacts the health and economy of modern society, and the prevention and treatment of obesity is a key focus of social research. The main reason for obesity is the excessive accumulation of body fat due to metabolic dysfunction, which may result in atherosclerosis, insulin resistance and abnormal lipid metabolism. So far, a number of mechanisms of intestinal flora and plant extracts have been found and applied to the treatment of obesity.

View Article and Find Full Text PDF